naltrexone and butorphanol

naltrexone has been researched along with butorphanol in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19905 (10.87)18.7374
1990's17 (36.96)18.2507
2000's13 (28.26)29.6817
2010's8 (17.39)24.3611
2020's3 (6.52)2.80

Authors

AuthorsStudies
Bousquet, AR; Howes, JF; Kotick, MP; Polazzi, JO1
Bousquet, AR; Howes, JF; Kotick, MP; Leland, DL; Polazzi, JO1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Bidlack, JM; Bu, Y; Cohen, DJ; Lou, R; Lu, Q; VanAlstine, MA; Wentland, MP1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M; Oh, KW2
Dykstra, LA1
Cho, TM; Nozaki, M1
Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM1
Hameroff, SR1
Billington, CJ; Grace, M; Levine, AS; Portoghese, PS1
Amundsen, L; Binstock, W; Cox, SM; Faure, EA; Glosten, B; Hibbard, J; Ismail, M; Moawad, AH; Senal, JA; Wittels, B1
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M1
Ho, IK; Hoskins, B; Jaw, SP2
Brandt, MR; France, CP1
Feng, YZ; Ho, IK; Rockhold, RW; Tokuyama, S; Zhang, T; Zhu, H1
Ho, IK; Hoshi, K; Ma, T; Oh, S1
Barton, C; Bray, GA; Ookuma, K; York, DA1
Burke, TF; Garner, HR; Lawhorn, CD; Stoner, JM; Wessinger, WD1
Feng, Y; Ho, IK; Rockhold, RW1
He, Z; Ho, IK; Tsang, BK; Wongchanapai, W1
Butelman, ER; Ko, MC; Mosberg, HI; Sobczyk-Kojiro, K; Van Bemmel, B; Woods, JH; Zernig, G1
Morgan, D; Picker, MJ1
Aguilar, R; Bailey, JE; Foerster, CR; Foerster, SH; Loria, DL1
Childs, SE; Ferrell, ST; Radcliffe, RW1
Hendrickson, DA; Radcliffe, RM; Radcliffe, RW; Richardson, GL; Zuba, JR1
Billington, CJ; Grace, MK; Jewett, DC; Jones, RM; Levine, AS; Portoghese, PS1
Ho, IK; Rockhold, RW; Sinchaisuk, S1
David Clark, J; Demirci, H; Gharagozlou, P; Lameh, J1
Craft, RM; McNiel, DM1
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT1
Spelman, LH1
Bigelow, GE; Chausmer, AE; Strain, EC; Walsh, SL1
Calle, PP; Georoff, TA; James, SB; Kalk, P; Martin-Flores, M1
Li, M; McMillan, DE; Wessinger, WD1
Anisimova, VA; Grechko, OIu; Spasov, AA1
Anisimova, VA; Grechko, OIu; Shtareva, DM; Spasov, AA1
Hayek, LC; Marker, L; Murray, S; Sanchez, CR; Woc Colburn, AM1
Balhara, YPS; Gupta, R; Sarkar, S; Shah, B1
Fisher, MC; Mays, T; Miller, MW; Wolfe, LL1
Gardner, BR; Kotze, PGH; McCue, SA; Musson, M; Seakamela, SM; Spolander, B1
Anderson, NE; Delnatte, P; Dutton, C; Ferro, A; Larouche, CB; Milnes, EL; Skelding, AM1

Reviews

2 review(s) available for naltrexone and butorphanol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Contemporary anesthesia practice, 1983, Volume: 7

    Topics: Analgesics, Opioid; Buprenorphine; Butorphanol; Endorphins; Humans; Nalbuphine; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid

1983

Trials

5 trial(s) available for naltrexone and butorphanol

ArticleYear
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes.
    Anesthesia and analgesia, 1993, Volume: 77, Issue:5

    Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Butorphanol; Cesarean Section; Female; Humans; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Pregnancy; Prospective Studies

1993
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
    Psychopharmacology, 2008, Volume: 196, Issue:1

    Topics: Adult; Affect; Arousal; Butorphanol; Diuresis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Naltrexone; Narcotic Antagonists; Narcotics; Perception; Premedication; Receptors, Opioid, kappa; Receptors, Opioid, mu

2008
Evaluation of medetomidine-ketamine-butorphanol anesthesia with atipamezole-naltrexone antagonism in captive male guanacos (Lama guanicoe).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2010, Volume: 41, Issue:2

    Topics: Adrenergic alpha-Antagonists; Anesthetics; Animals; Butorphanol; Camelids, New World; Imidazoles; Ketamine; Male; Medetomidine; Naltrexone; Narcotic Antagonists

2010
CARDIORESPIRATORY EFFECTS OF DEXMEDETOMIDINE-BUTORPHANOL-MIDAZOLAM (DBM): A FULLY REVERSIBLE ANESTHETIC PROTOCOL IN CAPTIVE AND SEMI-FREE-RANGING CHEETAHS (ACINONYX JUBATUS).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2017, Volume: 48, Issue:1

    Topics: Acinonyx; Analgesics, Opioid; Anesthesia; Animals; Animals, Zoo; Butorphanol; Dexmedetomidine; Drug Therapy, Combination; Female; Heart Rate; Hypnotics and Sedatives; Imidazoles; Male; Midazolam; Naltrexone; Respiration

2017
A randomized clinical trial to compare ketamine-butorphanol-azaperone-medetomidine and detomidine-etorphine-acepromazine for anesthesia of captive Przewalski horses (Equus przewalskii).
    American journal of veterinary research, 2022, May-08, Volume: 83, Issue:6

    Topics: Acepromazine; Anesthesia; Animals; Azaperone; Butorphanol; Etorphine; Heart Rate; Horses; Hypnotics and Sedatives; Hypoxia; Imidazoles; Immobilization; Ketamine; Medetomidine; Naltrexone; Oxygen; Prospective Studies

2022

Other Studies

39 other study(ies) available for naltrexone and butorphanol

ArticleYear
Analgesic narcotic antagonists. 9. 6-Methylene-8 beta-alkyl-N-(cycloalkylmethyl)-3-hydroxy- or -methoxymorphinans.
    Journal of medicinal chemistry, 1981, Volume: 24, Issue:12

    Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Substance Withdrawal Syndrome

1981
Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones.
    Journal of medicinal chemistry, 1981, Volume: 24, Issue:12

    Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Hydrocodone; In Vitro Techniques; Mice; Narcotic Antagonists; Rats; Reaction Time

1981
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.
    Bioorganic & medicinal chemistry letters, 2009, Jan-01, Volume: 19, Issue:1

    Topics: Amides; Analgesics, Opioid; Humans; Protein Binding; Receptors, Opioid; Structure-Activity Relationship; Tramadol

2009
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Effects of beta-funaltrexamine on butorphanol dependence.
    Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:1

    Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Butorphanol; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders

1992
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Dose-Response Relationship, Drug; Levallorphan; Male; Methadone; Morphinans; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri

1990
Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor.
    Journal of neurochemistry, 1985, Volume: 45, Issue:2

    Topics: Animals; Butorphanol; Cell Membrane; Dihydromorphine; Diprenorphine; Dithionitrobenzoic Acid; Dithiothreitol; Etorphine; Morphine; Nalorphine; Naloxone; Naltrexone; Nitrobenzoates; Oxymorphone; Rats; Receptors, Opioid

1985
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu

1987
Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol.
    European journal of pharmacology, 1994, May-12, Volume: 257, Issue:1-2

    Topics: Animals; Butorphanol; Injections, Intraventricular; Male; Naloxone; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders

1994
The effect of selective opioid antagonists on butorphanol-induced feeding.
    Brain research, 1994, Feb-21, Volume: 637, Issue:1-2

    Topics: Animals; Butorphanol; Dose-Response Relationship, Drug; Feeding Behavior; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

1994
Effects of nor-binaltorphimine on butorphanol dependence.
    European journal of pharmacology, 1993, Aug-03, Volume: 239, Issue:1-3

    Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor

1993
Opioid antagonists and butorphanol dependence.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:3

    Topics: Animals; Behavior, Animal; Butorphanol; Indoles; Injections, Intraventricular; Male; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome

1993
Involvement of delta-opioid receptors in physical dependence on butorphanol.
    European journal of pharmacology, 1993, Aug-10, Volume: 240, Issue:1

    Topics: Animals; Butorphanol; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substance-Related Disorders

1993
Discriminative stimulus effects on enadoline in pigeons.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2

    Topics: Animals; Benzofurans; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Dynorphins; Nalbuphine; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa

1996
Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Neurochemical research, 1996, Volume: 21, Issue:1

    Topics: Animals; Butorphanol; Drug Evaluation, Preclinical; Injections, Intraventricular; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Substance Withdrawal Syndrome

1996
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
    Brain research, 1997, Apr-04, Volume: 753, Issue:1

    Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders

1997
Effect of enterostatin and kappa-opioids on macronutrient selection and consumption.
    Peptides, 1997, Volume: 18, Issue:6

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Colipases; Dietary Carbohydrates; Dietary Fats; Eating; Enzyme Precursors; Food Preferences; Male; Naltrexone; Narcotic Antagonists; Narcotics; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa

1997
Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Butorphanol; Male; Mice; Morphine; Naltrexone; Pyrrolidines; Receptors, Opioid, mu

1997
Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2

    Topics: Animals; Butorphanol; Excitatory Amino Acids; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome

1997
Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:3

    Topics: Analgesics, Opioid; Animals; Butorphanol; Dose-Response Relationship, Drug; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid

1998
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:2

    Topics: Analgesics, Opioid; Animals; Benzofurans; Brain Chemistry; Butorphanol; Dose-Response Relationship, Drug; Hot Temperature; Macaca mulatta; Nalbuphine; Naltrexone; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa

1998
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Psychopharmacology, 1998, Volume: 140, Issue:1

    Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu

1998
Butorphanol/xylazine/ketamine immobilization of free-ranging Baird's tapirs in Costa Rica.
    Journal of wildlife diseases, 2000, Volume: 36, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Animals, Wild; Blood Gas Analysis; Blood Pressure; Butorphanol; Costa Rica; Electrocardiography; Female; Heart Rate; Immobilization; Ketamine; Male; Naltrexone; Narcotic Antagonists; Oximetry; Perissodactyla; Respiration; Tolazoline; Xylazine; Yohimbine

2000
Butorphanol and azaperone as a safe alternative for repeated chemical restraint in captive white rhinoceros (Ceratotherium simum).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2000, Volume: 31, Issue:2

    Topics: Analgesics, Opioid; Anesthetics, Combined; Animals; Azaperone; Butorphanol; Female; Heart Rate; Hypnotics and Sedatives; Immobilization; Injections, Intramuscular; Male; Naltrexone; Oximetry; Perissodactyla

2000
Standing laparoscopic-guided uterine biopsy in a southern white rhinoceros (Ceratotherium simum simum).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2000, Volume: 31, Issue:2

    Topics: Analgesics, Opioid; Animals; Anti-Infective Agents; Azaperone; Biopsy; Butorphanol; Dinoprost; Dinoprostone; Female; Hypnotics and Sedatives; Hysteroscopy; Laparoscopy; Naltrexone; Perissodactyla; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography; Uterus; Vulva

2000
The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
    Brain research, 2001, Aug-03, Volume: 909, Issue:1-2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Brain; Butorphanol; Drug Interactions; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Deprivation; Guanidines; Male; Morphinans; Naltrexone; Narcotic Antagonists; Narcotics; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa

2001
Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 74, Issue:1

    Topics: Animals; Basal Ganglia; Butorphanol; Diffusion; Electric Stimulation; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome

2002
Activity of opioid ligands in cells expressing cloned mu opioid receptors.
    BMC pharmacology, 2003, Jan-04, Volume: 3

    Topics: Azocines; beta-Endorphin; Binding, Competitive; Butorphanol; Cell Line; Colforsin; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Etorphine; Fentanyl; Humans; Hydromorphone; Ligands; Morphine; Naltrexone; Phenazocine; Radioligand Assay; Receptors, Opioid, mu; Tritium

2003
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:1

    Topics: Animals; Benzeneacetamides; Butorphanol; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Urination

2003
Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.
    Journal of neuroscience research, 2003, Jun-15, Volume: 72, Issue:6

    Topics: Animals; Brain; Butorphanol; Dose-Response Relationship, Drug; Male; Naltrexone; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders

2003
Reversible anesthesia of captive California sea lions (Zalophus californianus) with medetomidine, midazolam, butorphanol, and isoflurane.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2004, Volume: 35, Issue:1

    Topics: Anesthetics, Combined; Anesthetics, Inhalation; Animals; Antidotes; Butorphanol; Dose-Response Relationship, Drug; Female; Flumazenil; Heart Rate; Hypnotics and Sedatives; Imidazoles; Immobilization; Isoflurane; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists; Narcotics; Respiration; Sea Lions; Time Factors

2004
Drug discrimination in pigeons trained to discriminate among morphine, U50488, a combination of these drugs, and saline.
    Behavioural pharmacology, 2011, Volume: 22, Issue:5-6

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Ethylketocyclazocine; Male; Morphine; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reinforcement Schedule; Sodium Chloride

2011
[Model of platelet activation as experimental test system for screening kappa-opioid receptor ligands].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:8

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Benzimidazoles; Blood Platelets; Butorphanol; High-Throughput Screening Assays; Ligands; Light; Naltrexone; Platelet Activation; Rabbits; Receptors, Opioid, kappa; Scattering, Radiation

2011
[Analgesic properties of morpholinoethylimidazobenzimidazole derivative RU-1205].
    Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:9

    Topics: Analgesics; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Male; Mice; Morpholines; Naloxone; Naltrexone; Narcotic Antagonists; Nociception; Pain; Pain Measurement; Rats; Receptors, Opioid, kappa

2013
Injection Butorphanol dependence: A case report.
    Asian journal of psychiatry, 2018, Volume: 35

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Butorphanol; GABA Modulators; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nitrazepam; Opiate Substitution Treatment; Opioid-Related Disorders

2018
Tissue Residue Levels of the Tranquilizer Combination of Butorphanol, Azaperone, and Medetomidine, and the Antagonists, Naltrexone, Atipamezole, and Tolazoline, in Black Bears (Ursus americanus) Postimmobilization.
    Journal of wildlife diseases, 2020, 10-01, Volume: 56, Issue:4

    Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Antihypertensive Agents; Azaperone; Butorphanol; Drug Combinations; Drug Residues; Hypnotics and Sedatives; Imidazoles; Immobilization; Medetomidine; Naltrexone; Narcotic Antagonists; Tolazoline; Ursidae

2020
Disentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol.
    Journal of the South African Veterinary Association, 2021, May-21, Volume: 92, Issue:0

    Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Butorphanol; Conscious Sedation; Drug Combinations; Fur Seals; Hypnotics and Sedatives; Imidazoles; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists

2021